Amplify ETF Trust Amplify Natural Resources Dividend Income ETF (ARCA: NDIV)

Dernières nouvelles pour Amplify ETF Trust Amplify Natural Resources Dividend Income ETF (ARCA:NDIV)

Amplify ETF Trust Amplify Natural Resources Dividend Income ETF

Energy

Basic Materials

The Fund will normally invest at least 80 Percent of its net assets (plus borrowings for investment purposes) in the securities that comprise the Index, which primarily include common stocks and/or depositary receipts. Using an indexing investment approach, the Fund attempts to replicate, before fees and expenses, the performance of the Index. The Fund generally will use a replication methodology, meaning it will invest in all of the underlying securities comprising the Index in proportion to each securitys weightings in the Index. However, the Fund may utilize a sampling methodology under various circumstances where it may not be possible or practicable to purchase all of the underlying securities in the Index. The Funds investment sub-adviser, Toroso Investments, LLC (Toroso, the Sub-Adviser) manages the investment of the Funds assets. The index provider is EQM Indexes LLC. (EQM or the Index Provider). The Index Provider is not affiliated with the Fund, the Funds investment adviser, Amplify Investments LLC (the Adviser), or the Sub-Adviser.

Petroleo Brasileiro Sa - Petrobras Adr

Western Midstream Partners Lp

Mplx Lp

Energy Transfer Lp

B2Gold Corp

Plains All American Pipeline, L.p., Series B

Enterprise Products Partners Lp

Sunoco, Lp

Dorchester Minerals Lp Mlp

Flex Lng Ltd

Lyondellbasell Inds. Nv

Black Stone Minerals L.p.

Delek Logistics

Alliance Resource Partners Lp

Kimbell Royalty Partners Lp

Cvr Energy Inc

Genesis Energy Lp

Chemours Co

Dow Inc.

Huntsman

Noble Corp Plc

Fmc Corp Fmc

Sitio Royalties Corp-A

Amplify Natural Resources Dividend Income ETF

NDIVISION INC by nDivision Inc.

NDivision Inc

News

PENN

PENN Entertainment Sends Letter to Shareholders; Says PENN Play Loyalty Member Base Has Grown 10% YoY And Says Expects To Accelerate Return Of Capital To Shareholders In The Second Half Of The Year And Repurchase At Least $350M Of Common Stock In Calendar 2025

WIIM

Foot Locker shares are trading higher after DICK's Sporting Goods agreed to acquire the company. Also, the company issued preliminary Q1 Non-GAAP EPS results.

Earnings

Earnings Beats

ABEO

Abeona Therapeutics Q1 EPS $(0.24) Beats $(0.36) Estimate

Rosenblatt analyst Mike Genovese maintains Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) with a Buy and raises the price target from $63 to $74.

Price Target

Analyst Ratings

CSCO

Rosenblatt Maintains Buy on Cisco Systems, Raises Price Target to $74

HC Wainwright &amp; Co. analyst Yi Chen maintains Sanara MedTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTI#NASDAQ">SMTI</a>) with a Buy and raises the price target from $51 to $53.

SMTI

HC Wainwright & Co. Maintains Buy on Sanara MedTech, Raises Price Target to $53

N2OFF to take part in financing a 35MW/140MWh planned Battery Energy Storage System project in Poland
Neve Yarak, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) (FSE:80W) ("N2OFF" and the "Company"), a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech, recently announced its entry into the Polish renewable energy market by participating in the financing of a Battery Energy Storage System (BESS) project in Poland.
The project, currently planned at 35MW/140MWh, represents a significant step in expanding Solterra's large-scale energy storage solutions in the region. N2OFF, along with other lenders, will assist with financing an initial payment under a signed grid connection agreement. Future development plans include applying for an increase in capacity to more than 100MW/400MWh.

NITO

N2OFF Enters Into Polish Renewable Energy Market By Participating In Financing Of Battery Energy Storage System Project In Poland

BHVN

Biohaven shares are trading lower after the FDA's Office of Neuroscience extended the PDUFA date for the troriluzole new drug application for the treatment of spinocerebellar ataxia by three months to provide time for a full review of the company's recent submissions related to information requests from the agency.

Earnings Misses

FTLF

FitLife Brands Q1 EPS $0.20 Misses $0.29 Estimate, Sales $15.94M Beat $15.77M Estimate

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cadrenal.com%2F&amp;esheet=54255465&amp;newsitemid=20250515408603&amp;lan=en-US&amp;anchor=Cadrenal+Therapeutics%2C+Inc.&amp;index=1&amp;md5=eb57e3bf892902967f302bae6cefbdca">Cadrenal Therapeutics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug candidate, tecarfarin, a novel oral vitamin K antagonist (VKA) anticoagulant that is designed to address unmet needs in anticoagulation therapy.
Cadrenal completed the technical transfer and manufacturing of its tecarfarin drug substance in accordance with current good manufacturing practices (cGMP) earlier this year at a U.S. site of a leading global Contract Development and Manufacturing Organization (CDMO). Manufacturing of the tecarfarin drug product candidate is currently underway.

CVKD

Cadrenal Therapeutics Announces Manufacturing And Supply Chain Milestones For Tecarfarin, Oral VKA Anticoagulant Designed To Address Unmet Needs In Anticoagulation Therapy

Needham analyst Ryan Koontz reiterates Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Buy and maintains $130 price target.

Reiteration

ANET

Needham Reiterates Buy on Arista Networks, Maintains $130 Price Target

NextPlat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPL#NASDAQ">NXPL</a>) reported quarterly losses of $(0.05) per share. This is a 37.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported $14.53 million in sales this quarter. This is a 16.97 percent decrease over sales of $17.49 million the same period last year.

NXPL

NextPlat Q1 EPS $(0.05) Up From $(0.08) YoY, Sales $14.53M Down From $17.49M YoY

ELEV

Elevation Oncology Q1 EPS $(0.24) Misses $(0.19) Estimate

Health Care

General

CYBN

Cybin Engages Thermo Fisher To Support Phase 3 Supply And Potential Commercial Manufacturing Of CYB003 In Development For Major Depressive Disorder

Auxly Cannabis Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) reported quarterly earnings of $0.01 per share. This is a 150 percent increase over losses of $(0.02) per share from the same period last year. The company reported $22.76 million in sales this quarter. This is a 21.53 percent increase over sales of $18.73 million the same period last year.

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

Auxly Cannabis Group Q1 GAAP EPS $0.01 Up From $(0.02) YoY, Sales $22.76M Up From $18.73M YoY

EDBL

Edible Garden AG Q1 EPS $(2.47) Beats $(3.03) Estimate, Sales $2.70M Miss $3.82M Estimate

Arthur Hayes, Chief Investment Officer of Maelstrom and co-founder of BitMEX on Thursday said that foreign capital repatriation and the devaluation of U.S. Treasury bonds will be the twin forces driving Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to $1 million within the <a href="https://in.benzinga.com/markets/25/05/45384424/great-progress-made-trump-says-traders-react-as-bitcoin-pops-then-stalls-at-key-resistance">next presidential cycle</a>.
What Happened: His thesis is rooted in structural imbalances in the U.S. trade and capital accounts and the political imperative to resolve them not through austerity, but through capital controls and money printing.
&#8220;Foreign capital repatriation and the devaluation of the gargantuan stock of U.S. treasuries will be the two catalysts that will power Bitcoin to $1 million sometime between now and 2028,&#8221; Hayes <a href="https://cryptohayes.substack.com/p/fatty-fatty-boom-boom">wrote</a>.
The essay dissects the growing tension between the U.S.'s reliance on foreign capital to finance its deficits and the political unwillingness to pursue hardline trade protectionism. 
Hayes argues that tariffs are an insufficient tool for rebalancing trade flows and are politically unsustainable in the short term, especially when they raise consumer prices. 
Instead, he predicts a shift to capital controls, specifically targeting the foreign ownership of U.S. financial assets like stocks, bonds and real estate.
Hayes envisions a 2% annual tax on foreign-owned financial assets, which he believes could generate enough revenue to eliminate income taxes for most U.S. households. 
"Trump could eliminate income taxes for the vast majority of voters by placing a 2% foreign capital tax on stocks, bonds, and property," he wrote.
This tax, he argues, would either discourage foreigners from accumulating U.S. assets, thus weakening the dollar and making U.S. exports more competitive, or allow capital inflows to continue while redistributing tax revenues domestically. 
"Either foreign capital stays, pays the tax, and revenue is used to eliminate income taxes… or foreign capital leaves, and American manufacturing grows," Hayes explained.
But foreign capital fleeing U.S. assets would have systemic implications. 
Hayes points out that the U.S. financial system is deeply reliant on steady demand for Treasury bonds, especially long-duration debt, and warns that a collapse in demand could trigger a surge in yields, destabilizing markets.
To counter this, Hayes predicts the Federal Reserve will resume quantitative easing (QE) and other expansionary measures to absorb the supply of Treasuries as foreign investors exit. 
"Bond prices will rise and yields collapse. The Fed will buy bonds due to its QE policy," he wrote.
In his view, this renewed round of money printing will debase U.S. debt and fiat savings, driving investors toward hard assets. 
Why It Matters: Hayes compares this to how U.S. Treasuries have already lost substantial purchasing power relative to Bitcoin and gold since 2021.
"Treasuries lost 64% and 84% of their value vs. gold and Bitcoin, respectively, from 2021 until the present," he stated, citing indexed ETF performance.
As the monetary system splinters under the weight of these imbalances, Hayes views Bitcoin as the only viable hedge for private capital. 
Unlike gold, which often requires intermediaries and custody solutions susceptible to regulatory interference, Bitcoin is a bearer asset that can be transferred without institutional permission.
&#8220;Bitcoin is the perfect and only lifeboat for global capital that must leave America and elsewhere,&#8221; Hayes declared.
He contends that even if 10% of the $33 trillion in foreign-owned U.S. portfolio assets were to rotate into Bitcoin, the price would not merely rise linearly but potentially explode due to constrained supply and liquidity. 
He envisions a potential "short squeeze of epic proportions" as traditional capital competes to enter the market.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45417306/michael-saylors-bitcoin-strategy-infinite-money-glitch-or-a-reflexive-leverage-bet">Michael Saylor&#8217;s Bitcoin Strategy—&#8217;Infinite Money Glitch&#8217; Or A Reflexive Leverage Bet?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Arthur Hayes Predicts Bitcoin To Hit $1 Million By 2028

Palvella Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PVLA#NASDAQ">PVLA</a>) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(1.44) by 48.61 percent.

PVLA

Palvella Therapeutics Q1 EPS $(0.74) Beats $(1.44) Estimate

INKT

MiNK Therapeutics Q1 EPS $(0.70) Beats $(0.71) Estimate

Ark Invest founder Cathie Wood says American power bills might have been roughly 90% cheaper had Washington not tightened the regulatory vice on nuclear energy in the 1970s, citing new in-house research released this week.
What Happened: Wood on Wednesday reposted analyst Sam Korus's thread on X, highlighting an Ark chart that shows nuclear construction costs veering sharply upward after a wave of safety rules, while solar kept sliding, ultimately flipping the cost hierarchy.
The underlying study argues that, adjusted for capacity factors, pre-1975 cost trends would make nuclear the cheapest source of baseload power today and lop roughly nine-tenths off retail electricity prices.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">According to <a href="https://twitter.com/ARKInvest?ref_src=twsrc%5Etfw">@ARKInvest</a>'s research on nuclear energy led by <a href="https://twitter.com/skorusARK?ref_src=twsrc%5Etfw">@skorusARK</a>, if government regulators had not interfered, electricity costs would be roughly 90% lower in the US than they are today. <a href="https://t.co/njsS6CRjr5">https://t.co/njsS6CRjr5</a>
&mdash; Cathie Wood (@CathieDWood) <a href="https://twitter.com/CathieDWood/status/1922826011638399313?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Nuclear's fortunes changed after the partial meltdown at Three Mile Island in March 1979, which triggered sweeping design and training mandates from the newly strengthened Nuclear Regulatory Commission. Academic <a href="https://www.sciencedirect.com/science/article/pii/S254243512030458X?">reviews</a> by ScienceDirect and Breakthrough Journal <a href="https://www.breakthroughjournal.org/p/its-the-nuclear-regulation-stupid">show</a> that those rules added at least 25% to reactor capital costs and stretched build times by more than two years on average.
See also: <a href="https://www.benzinga.com/general/health-care/25/05/45431505/gop-tax-bill-breaks-trumps-social-security-tax-pledge-still-hits-25-million-seniors-while-elon-musks-stock-wealth-skirts-fica">GOP Tax Bill Breaks Trump&#8217;s Social Security Tax Pledge, Still Hits 25 Million Seniors While Elon Musk&#8217;s Stock Wealth Skirts FICA</a>
Industry studies estimate labor and materials outlays <a href="https://ifp.org/nuclear-power-plant-construction-costs">jumped</a> another 10-15% in the early 1980s, cementing the cost spiral. By contrast, levelized solar prices have fallen more than 80% since 2010, leaving nuclear stranded without regulatory relief.
Why It Matters: Wood's nuke-friendly stance dovetails with <a href="https://www.benzinga.com/markets/equities/24/10/41442870/cathie-woods-ark-invest-buys-3-95m-worth-of-amazon-stock-amid-companys-nuclear-moves">Ark's bets</a> on companies pursuing advanced reactors and on customers such as Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) that are exploring in-house nuclear supply for data-center demands.
Ark Invest&#8217;s research also arrives after news broke earlier this week of President Donald Trump advancing a <a href="https://www.benzinga.com/25/05/45378427/trump-wants-to-kickstart-nuclear-development-these-5-stocks-could-boom">series of executive orders</a> aimed at dramatically changing U.S. nuclear energy policy to accelerate the construction of new nuclear power plants and reduce regulatory barriers.
Nuclear power developer Elementl Power on Wednesday <a href="https://www.benzinga.com/news/25/05/45337965/google-to-fund-three-nuclear-sites-says-the-move-will-allow-them-to-move-at-the-speed-required-to-meet-this-moment-of-ai-and-american-innovation">also revealed</a> that it had signed a strategic agreement with Google to develop three sites for advanced reactors.
Photo courtesy: ChrisStock82 / Shutterstock.com
Read next: <a href="https://www.benzinga.com/markets/equities/25/05/45430137/trump-had-a-problem-with-tim-cook-president-says-he-told-apple-ceo-i-dont-want-you-building-in-india-amid-tariff-concerns-and-production-shift-from-china">Trump Had A &#8216;Little Problem&#8217; With Apple CEO Tim Cook, Says &#8216;I Don&#8217;t Want You Building In India&#8217;</a>

Equities

Markets

AMZN

Cathie Wood Says US Electricity Prices Would Be 90% Lower Without Three Mile Island–Era Rules

HC Wainwright &amp; Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) with a Buy and maintains $100 price target.

BLTE

HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $100 Price Target

Comments

Amplify ETF Trust Amplify Natural Resources Dividend Income ETF

Actualités

Dernières nouvelles pour Amplify ETF Trust Amplify Natural Resources Dividend Income ETF (ARCA:NDIV)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL